跳至主要内容
临床试验/ACTRN12607000404426
ACTRN12607000404426尚未招募2 期

A study to evaluate the effectiveness of Posterior Capsule Stretches on increasing range, decreasing pain and increasing function in people with Subacromial Impingement Syndrome (SAIS)

Queensland Health0 个研究点目标入组 60 人开始时间: 2007年8月6日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 66 Years(—)
性别
All

入选标准

  • Patients with a clinical diagnosis of unilateral SAIS and at least four weeks duration of symptoms. The diagnosis will be based on the patients' history and a clinical examination, which will include the reproduction of pain with shoulder internal rotation at ninety degrees of flexion (Hawkins Test) and posterior shoulder tightness as indicated by a loss of more than 2 cm on crossed adduction shoulder measures when compared to the unaffected side (Tyler et al., 1999). All genders included.

排除标准

  • Patients will be excluded from the study if they have a history or current diagnosis of dislocation with an associated positive apprehension test, rotator cuff tears/rupture, adhesive capsulitis, acromioclavicular joint pathology, cervical spine pathology, neurological pathology, systemic disease affecting the upper limb (e.g. cancer or rheumatological disease), heart failure, radiological/imaging findings of internal derangement of the glenohumeral joint, bilateral upper limb pain, trauma to the upper limb within the previous four weeks, or physiotherapy treatment for this condition within the last six month (Desmeules et al., 2003).

研究者

相似试验

进行中(未招募)
1 期
An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study A” or Study B”) at Risk for Developing Sight-Threatening Choroidal Neovascularisation (CNV) Due to Exudative Age-Related Macular Degeneration (AMD). - Anecortave Acetate Risk Reduction Trial (AART)non-exudative age related macular degeneration (dry AMD)
EUCTR2005-001598-93-ESAlcon Research Limited2,500
进行中(未招募)
不适用
An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study A” or Study B”) at Risk for Developing Sight-Threatening Choroidal Neovascularisation (CNV) Due to Exudative Age-Related Macular Degeneration (AMD) - Anecortave Acetate Risk Reduction Trial (AART)non-exudative age related macular degeneration (dry AMD)
EUCTR2005-001598-93-DKAlcon Research Limited2,500
已完成
不适用
The clarification of influence that dialogue through support system give for clinical symptoms of dementia patient with hearing loss.dementia
JPRN-UMIN000037415Institute of Biomedical Sciences, Tokushima University Graduate School7
招募中
不适用
A prospective study for evaluation of efficacy of a 12mm diameter polytetrafluoroethylene partial covered stent in malignant extrahepatic biliary obstructio
KCT0005989Asan Medical Center161
已完成
2 期
A prospectve study to evaluate the efficacy of pregabalin for chemotherapy-induced peripheral nueralgiaPatients who suffers from peripehral neuralgia which is induced by antineaoplastic agents that were adeministered for therapy of hematological malignancies
JPRN-UMIN000005647Tokyo University, Dep. of Hematology and Oncology50